BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28610472)

  • 21. The role of preoperative mammography in women considering reduction mammoplasty: a single institution review of 207 patients.
    Campbell MJ; Clark CJ; Paige KT
    Am J Surg; 2010 May; 199(5):636-40. PubMed ID: 20466108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Routine Pathology Examination of Breast Tissue in Adolescent Reduction Mammaplasty: Not Cost Effective in a 7-Year Review.
    Hajebian HH; Puyana S; Mejia N; Van Wert MK; Babycos CR; Friel MT
    Ann Plast Surg; 2023 Jun; 90(6S Suppl 4):S416-S419. PubMed ID: 36975135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidental breast carcinoma: incidence, management, and outcomes in 4804 bilateral reduction mammoplasties.
    Tang R; Acevedo F; Lanahan C; Coopey SB; Yala A; Barzilay R; Li C; Colwell A; Guidi AJ; Cetrulo C; Garber J; Smith BL; Gadd MA; Specht MC; Hughes KS
    Breast Cancer Res Treat; 2019 Oct; 177(3):741-748. PubMed ID: 31317348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoma and atypical hyperplasia in reduction mammaplasty: increased sampling leads to increased detection. A prospective study.
    Ambaye AB; MacLennan SE; Goodwin AJ; Suppan T; Naud S; Weaver DL
    Plast Reconstr Surg; 2009 Nov; 124(5):1386-1392. PubMed ID: 20009822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast Cancer Detection by Preoperative Imaging in Reduction Mammaplasty Patients: A Single Center Study of 918 Patients.
    Merkkola-von Schantz PA; Kauhanen SMC; Jahkola TA; Krogerus LA; Hukkinen KS
    World J Surg; 2017 Aug; 41(8):2013-2019. PubMed ID: 28255630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence of non-proliferative and precancerous lesions of reduction mammoplasty: evaluation of 273 cases.
    Samdanci ET; Firat C; Cakir E; Ak M; Sayin S; Nurkabul Z
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1207-11. PubMed ID: 22165684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of reduction mammoplasty on the quality of life of obese patients suffering from symptomatic macromastia: A descriptive cohort study.
    Hernanz F; Fidalgo M; Muñoz P; Noriega MG; Gómez-Fleitas M
    J Plast Reconstr Aesthet Surg; 2016 Aug; 69(8):e168-73. PubMed ID: 27344408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathologic findings in breast reduction specimens.
    Kececi Y; Tasli FA; Yagcı A; Sır E; Canpolat S; Vardar E
    J Plast Surg Hand Surg; 2014 Apr; 48(2):122-5. PubMed ID: 23879776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathology Evaluation of Reduction Mammaplasty Specimens and Subsequent Diagnosis of Malignant Breast Disease: A Claims-Based Analysis.
    Sears ED; Lu YT; Chung TT; Momoh AO; Chung KC
    World J Surg; 2019 Jun; 43(6):1546-1553. PubMed ID: 30719555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction mammoplasty is beneficial in women with and without history of breast cancer.
    Desouki MM
    Womens Health (Lond); 2015 Jul; 11(4):419-22. PubMed ID: 26245153
    [No Abstract]   [Full Text] [Related]  

  • 31. Incidence of abnormal mammograms after reduction mammoplasty: implications for oncoplastic closure.
    Roberts JM; Clark CJ; Campbell MJ; Paige KT
    Am J Surg; 2011 May; 201(5):611-4. PubMed ID: 21545908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early complications of a reduction mammoplasty technique in the treatment of macromastia with or without breast cancer.
    Gulcelik MA; Dogan L; Camlibel M; Karaman N; Kuru B; Alagol H; Ozaslan C
    Clin Breast Cancer; 2011 Dec; 11(6):395-9. PubMed ID: 21993009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is macromastia a risk factor for breast cancer? A study on 198 patients.
    Talghini S
    Pak J Biol Sci; 2013 Nov; 16(21):1348-52. PubMed ID: 24511745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical management of the patient with invasive carcinoma discovered at reduction mammoplasty.
    Rudolph R; Niedbala AR
    Am Surg; 2003 Nov; 69(11):1003-5. PubMed ID: 14627265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncoplastic reduction mammoplasty for breast cancer in women with macromastia: Oncological long-term outcomes.
    Emiroglu M; Salimoglu S; Karaali C; Sert I; Gungor O; Sert F; Aydın C
    Asian J Surg; 2017 Jan; 40(1):41-47. PubMed ID: 26358362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of Occult Malignancies in Reduction Mammoplasties.
    Waldner M; Klein HJ; Künzi W; Guggenheim M; Plock JA; Giovanoli P
    Front Surg; 2018; 5():17. PubMed ID: 29564332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rate of incidental atypical and malignant breast lesions in reduction mammoplasty specimens.
    Genco IS; Steinberg J; Caraballo Bordon B; Tugertimur B; Dec W; Hajiyeva S
    Histopathology; 2020 Jun; 76(7):988-996. PubMed ID: 32043273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast lesions in reduction mammaplasty specimens: a histopathological pattern in 534 patients.
    Tadler M; Vlastos G; Pelte MF; Tille JC; Bouchardy C; Usel M; Pittet-Cuénod B; Modarressi A
    Br J Cancer; 2014 Feb; 110(3):788-91. PubMed ID: 24231955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathological evaluation of reduction mammaplasty specimens to detect occult breast cancer: a report from southern iran.
    Rajabian MH; Vijayananda Kumar P
    World J Plast Surg; 2012 Jul; 1(2):71-5. PubMed ID: 25734047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic findings in reduction mammaplasty specimens.
    Ishag MT; Bashinsky DY; Beliaeva IV; Niemann TH; Marsh WL
    Am J Clin Pathol; 2003 Sep; 120(3):377-80. PubMed ID: 14502800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.